Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;21(8):1203-1216.
doi: 10.1007/s13770-024-00668-8. Epub 2024 Oct 3.

Exosomes-Shuttled lncRNA SNHG7 by Bone Marrow Mesenchymal Stem Cells Alleviates Osteoarthritis Through Targeting miR-485-5p/FSP1 Axis-Mediated Chondrocytes Ferroptosis and Inflammation

Affiliations

Exosomes-Shuttled lncRNA SNHG7 by Bone Marrow Mesenchymal Stem Cells Alleviates Osteoarthritis Through Targeting miR-485-5p/FSP1 Axis-Mediated Chondrocytes Ferroptosis and Inflammation

Yue Wang et al. Tissue Eng Regen Med. 2024 Dec.

Abstract

Background: Osteoarthritis (OA), a degenerative joint disorder, is a major reason of disability in adults. Accumulating evidences have proved that bone marrow mesenchymal stem cells (BMSCs)-carried exosomes play a significant therapeutic effect on OA. However, the precise regulatory network remains unknown.

Methods: OA and normal cartilage samples were acquired from patients, and chondrocytes were exposed to IL-1β to conduct a cellular OA model. Exosomes prepared from BMSCs were identified using nanoparticle tracking analysis (NTA) and transmission electron microscopy (TEM). Cell viability was determined with CCK-8 assay. Inflammatory injury was assessed by LDH and inflammatory factors (TNF-α and IL-6) using corresponding ELISA kits, respectively. Ferroptosis was evaluated by GSH, MDA and iron levels using corresponding kits, and ROS level with DCFH-DA. The expressions of genes/proteins were determined with RT-qPCR/western bolt. RNA immunoprecipitation and luciferase activity assay were conducted for testing the interactions of small nucleolar RNA host gene 7 (SNHG7)/ferroptosis suppressor protein 1 (FSP1) and miR-485-5p.

Results: The expressions of SNHG7 and FSP1 were both reduced in IL-1β-induced chondrocytes and OA cartilage tissues, and there was a positive correlation between them in clinical level. Moreover, SNHG7 was enriched in BMSCs-derived exosomes (BMSCs-Exos) and could be internalized by chondrocytes. Functional analysis illustrated that BMSCs-Exos administration repressed inflammatory injury, oxidative stress and ferroptosis in IL-1β-induced chondrocytes, while these changes were reinforced when SNHG7 was overexpressed in BMSCs-Exos. Notably, FSP1 silencing in chondrocytes abolished the beneficial effects mediated by exosomal SNHG7.

Conclusions: Exosomal SNHG7 released from BMSCs inhibited inflammation and ferroptosis in IL-1β-induced chondrocytes through miR-485-5p/FSP1 axis. This work suggested that BMSCs-derived exosomal SNHG7 would be a prospective target for OA treatment.

Keywords: Bone marrow mesenchymal stem cells; Exosomes; Ferroptosis; Inflammation; MiR-485-5p/FSP1; Osteoarthritis; SNHG7.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors declare that they have no conflict of interest. Ethics statement: This research was approved by the Research Ethics Committee of our hospital (Approval number: KY2023024).

Figures

Fig. 1
Fig. 1
The abnormal expression of SNHG7 and FSP1 in OA patients and chondrocytes. OA and normal cartilage tissues were collected from OA patients (n = 29) and patients without OA or RA (n = 12). AB The levels of SNHG7 RNA and FSP mRNA were detected by RT-qPCR. c Western blot detection of FSP1 protein. D Pearson analysis for evaluating the correlation of SNHG7 and FSP1. Chondrocytes were treated by IL-1β (10 ng/mL) for 24 h. EG The RNA level of SNHG7 was detected by RT-qPCR. FG FSP1 mRNA and protein were detected by RT-qPCR and western blot, respectively. Data are means ± SD. *p < 0.05, **p < 0.01
Fig. 2
Fig. 2
SNHG7 was enriched in BMSCs-Exos and could be absorbed by chondrocytes. A TEM image of exosomes isolated from BMSCs. B The size distribution of exosomes determined by NTA. C Western blot for examining exosomes-specific proteins (CD9, CD63 and CD81). D SNHG7 was detected by agarose gel electrophoresis after amplification by specific primer. E, F BMSCs were transfected with pcDNA3.1 vectors or pcDNA3.1-SNHG7 vectors, respectively. EF RT-qPCR was performed for determining the RNA level of SNHG7 in BMSCs and BMSCs-Exos. G Chondrocytes was co-cultured with PKH67-labed BMSCs-Exos, the internalization efficiency was determined by immunofluorescence. Exosomes derived from BMSCs-transfected with pcDNA3.1 vectors or pcDNA3.1-SNHG7 vectors (Exos−vector, Exos−SNHG7) were added into IL-1β-treated chondrocytes. HI The levels of SNHG7 RNA and FSP mRNA were detected by RT-qPCR. Data are means ± SD. *p < 0.05, **p < 0.01
Fig. 3
Fig. 3
SNHG7 delivered by BMSCs-Exos alleviated IL-1β-triggered inflammatory injury in chondrocytes via upregulation of FSP1. A Chondrocytes were transfected with shNC or shFSP1, respectively. FSP1 mRNA was detected by RT-qPCR. Chondrocytes divided into following group: control, IL-1β, IL-1β + Exos−vector, IL-1β + Exos−SNHG7, IL-1β + Exos−SNHG7 + shNC, IL-1β + Exos.−SNHG7 + shFSP1. B FSP1 mRNA was detected by RT-qPCR. C Cell viability detection by CCK-8. D LDH release detected by corresponding kit. EF TNF-α and IL-6 levels were tested by ELISA. Data are means ± SD. *p < 0.05, **p < 0.01
Fig. 4
Fig. 4
Exosomal SNHG7 secreted by BMSCs inhibited IL-1β-triggered ferroptosis by elevating FSP1. Chondrocytes were divided into following groups: control, IL-1β, IL-1β + Exos−vector, IL-1β + Exos−SNHG7, IL-1β + Exos−SNHG7 + shNC, IL-1β + Exos−SNHG7 + shFSP1. A, B ELISA assay for measuring the levels of GSH activity and MDA level. C DCFH-DA staining for measuring ROS level. D Fe.2+ was determined by commercial kit. E Western blot for detecting GPX4 and PTGS2 protein levels. Data are means ± SD. *p < 0.05, **p < 0.01
Fig. 5
Fig. 5
SNHG7 upregulated FSP1 expression by sponging miR-485-5p. A Image of predicted miRNAs which both interacted with SNHG7 and FSP1 3′-UTR. Chondrocytes were transfected with pcDNA3.1 vectors or pcDNA3.1-SNHG7 vectors, respectively. B The RNA level of SNHG7 was detected by RT-qPCR. C RT-qPCR for testing the levels of miRNAs including hsa-miR-485-5p, hsa-miR-224-5p, hsa-miR-146a-5p, hsa-miR-186-5p, hsa-miR-146b-5p, hsa-miR-214-5p and hsa-miR-543. D RT-qPCR was used to detect miRNAs levels in chondrocytes with/without IL-1β treatment. E Image of the predicted binding sites between SNHG7 and miR-485-5p. f, G The binding relationship between SNHG7 and miR-485-5p was validated by Dual luciferase reporter assay (F) and RIP (G). H Image of predicted binding site between FSP1 3′-UTR and miR-485-5p. I Dual luciferase reporter assay for detecting the relationship of SNHG7 and miR-485-5p. J Chondrocytes were transfected with mimics NC or miR-485-5p mimics, then miR-485-5p level was detected by RT-qPCR. K Chondrocytes were transfected with pcDNA3.1-SNHG7 vectors or co-transfected with pcDNA3.1-SNHG7 vectors plus miR-485-5p mimics. FSP1 mRNA was detected by RT-qPCR. Data are means ± SD. *p < 0.05, **p < 0.01
Fig. 6
Fig. 6
MiR-485-5p overexpression reversed the role of exosomal SNHG7 in IL-1β-stimulated inflammatory injury. Chondrocytes were divided into following groups: IL-1β, IL-1β + Exos−vector, IL-1β + Exos−SNHG7, IL-1β + Exos.−SNHG7 + miR-485-5p mimics. A Cell viability detection by CCK-8. B LDH release detected by corresponding kit. CD TNF-α and IL-6 levels were tested by ELISA. Data are means ± SD. *p < 0.05, **p < 0.01
Fig. 7
Fig. 7
MiR-485-5p overexpression diminished the protective role of exosomal SNHG7 in IL-1β-induced ferroptosis. Chondrocytes were divided into following groups: IL-1β, IL-1β + Exos−vector, IL-1β + Exos−SNHG7, IL-1β + Exos−SNHG7 + miR-485-5p mimics. A, B ELISA assay for measuring the levels of GSH activity and MDA level. C DCFH-DA staining for measuring ROS level. D Fe.2+ was determined by commercial kit. E Western blot for detecting GPX4 and PTGS2 protein levels. Data are means ± SD. *p < 0.05, **p < 0.01

References

    1. Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis: a review. JAMA. 2021;325:568–78. - DOI - PMC - PubMed
    1. Samvelyan HJ, Hughes D, Stevens C, Staines KA. Models of osteoarthritis: relevance and new insights. Calcif Tissue Int. 2021;109:243–56. - DOI - PMC - PubMed
    1. Abramoff B, Caldera FE. Osteoarthritis: pathology, diagnosis, and treatment options. Med Clin North Am. 2020;104:293–311. - DOI - PubMed
    1. Charlier E, Deroyer C, Ciregia F, Malaise O, Neuville S, Plener Z, Malaise M, de Seny D. Chondrocyte dedifferentiation and osteoarthritis (OA). Biochem Pharmacol. 2019;165:49–65. - DOI - PubMed
    1. Salucci S, Falcieri E, Battistelli M. Chondrocyte death involvement in osteoarthritis. Cell Tissue Res. 2022;389:159–70. - DOI - PMC - PubMed

Publication types

LinkOut - more resources